Dow Up0.11% Nasdaq Up0.50%

Conatus Pharmaceuticals Inc. (CNAT)

-NasdaqGM
6.89 Up 0.16(2.38%) Aug 29, 4:00PM EDT
Insider RosterGet Insider Roster for:
Insider Holders*
Individual/EntityMost Recent Trans.Shares Owned as of Trans. Date
ABERDARE GP III, L.L.C.
Other
Acquisition (Non Open Market)
Feb 19, 2014
0

Feb 19, 2014
ADVENT VENTURE PARTNERS LLP
Beneficial Owner (10% or more)
Option Exercise
Jul 30, 2013
2,166,836

Jul 30, 2013
BURGESS GARY C.
Officer
Ownership Statement
Jul 24, 2013
121,212
Jul 24, 2013
CASHION CHARLES
Officer
Acquisition (Non Open Market)
Jul 30, 2013
149,738

Jul 30, 2013
COOPERATIVE GILDE HEALTHCARE II U.A.
Beneficial Owner (10% or more)
Option Exercise
Jul 30, 2013
1,487,320
Jul 30, 2013
EVNIN LUKE
Beneficial Owner (10% or more)
Purchase
Jul 30, 2013
1,192,080

Jul 30, 2013
HALE DAVID F
Director
Option Exercise
Jan 8, 2014
167,981
Jan 8, 2014
KISNER DANIEL L
Director
Acquisition (Non Open Market)
Feb 19, 2014
3,145
Feb 19, 2014
KLINGENSTEIN PAUL H
Director
Acquisition (Non Open Market)
Feb 19, 2014
56,956
Feb 19, 2014
LACASSE LOUIS P
Director
Purchase
Jul 30, 2013
809,887

Jul 30, 2013
MALIK SHAHZAD
Director
Option Exercise
Jul 30, 2013
2,166,836

Jul 30, 2013
MENTO STEVEN J
Officer
Purchase
Jul 30, 2013
385,669

Jul 30, 2013
MPM BIOVENTURES IV QP LP
Beneficial Owner (10% or more)
Purchase
Jul 30, 2013
1,192,080

Jul 30, 2013
PERRET MARC OLIVIER
Director
Sale
Jul 30, 2013
1,487,320

Jul 30, 2013
SCOPA JAMES PAUL
Director
Purchase
Jul 30, 2013
1,192,080

Jul 30, 2013
SPADA ALFRED P.
Officer
Acquisition (Non Open Market)
Jul 30, 2013
235,021

Jul 30, 2013

View Transactions for Insiders & Institutional Holders

 
* Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.